Researchers have discovered a strong association between the use of immune checkpoint inhibitors for cancer treatment and a ...

Being diagnosed with colon cancer at 34 was difficult, but choosing happiness and acceptance helped me find peace through ...

Among phlebotomy-dependent patients with polycythemia vera, the addition of rusfertide to standard-of-care treatment resulted ...

It was a Friday afternoon, and I was sitting in slow-moving traffic on FM 1960 in Houston, on my way to spend the night at my ...

The FDA has accepted the resubmission of the BLA of Ordspono for review in relapsed/refractory follicular lymphoma following previous systemic therapy.

The first patient has been dosed in a first-in-human clinical trial evaluating HLD-0915 for metastatic castration-resistant ...

The first patient with small cell lung cancer has been dosed in a trial of peluntamig (PT217) combined with chemotherapy.

Camizestrant with a CDK 4/6 inhibitor had a statistically significant and clinically meaningful improvement in PFS in ...

Dr. Frederick L. Locke sat down with CURE® to discuss treatment with cema-cel in the ALPHA/ALPHA2 studies for ...

Chemoradiation improves survival in cervical cancer patients, but benefits may decline after age 80, according to a study ...

I was told my lymphoma had worsened, but a miraculous turn of events spared me from aggressive chemotherapy, making me ...

Datroway demonstrated durable antitumor activity and an acceptable safety profile in advanced NSCLC with actionable genomic ...